Market Overview:
The global IVD raw materials market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for diagnostic tests, technological advancements in the field of diagnostics, and rising prevalence of diseases. The global IVD raw materials market is segmented on the basis of type into antigen, antibody, and diagnostic enzymes. The antigen segment is expected to grow at a CAGR of 7.0% during the forecast period from 2018 to 2030. This growth can be attributed to the increasing demand for vaccines and growing awareness about preventive healthcare measures among consumers worldwide.
Product Definition:
IVD raw materials are the components used to create medical devices that test and diagnose diseases. They are important because they allow for the safe and accurate diagnosis of a variety of health conditions. Without them, it would be difficult or impossible to make many of the tests and diagnostics that we rely on today.
Antigen:
Antigen is the substance that causes the immune system to respond when it comes in contact with an infected person. The antibodies produced by the body during an infection are called antigens. They are used in various medical procedures such as Rheumatoid arthritis, Cancer diagnosis and treatment, Autoimmune diseases testing etc.
IVD raw materials market includes products such as reagents & kits used for molecular diagnostics tests.
Antibody:
Antibody is a protein that is produced by the immune system in response to an antigen. The most commonly used antibodies are those that are produced in response to the insulin gene product, which occurs in both humans and other species as well. Antibodies can be classified on the basis of their functions into immunoglobulins (antibodies, antibody binding proteins), monoclonal antibodies (MABs), and polyclonal antibodies (PAb).
Application Insights:
The pharmaceutical company segment dominated the global IVD raw materials market in 2017. The growth of this segment can be attributed to an increase in demand for innovative and advanced drugs, coupled with a growing preference for expensive medicines among several countries across the globe. For instance, according to data published by WHO in 2018, around 1 out of 10 deaths occur due to cardiovascular diseases globally. Moreover, as per estimates published by International Society of Aesthetic Plastic Surgery (ISAPS), around USD 250 billion is spent annually on aesthetic surgeries globally. This trend is expected to drive demand for diagnostics products over the forecast period as well since these procedures require specific equipment and skilled professionals who use high-quality materials during their operations.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of global players, advanced healthcare infrastructure and high adoption rate for new technologies are some factors attributing to its largest share. Moreover, increasing demand for medical tests that can be conducted online is expected to further fuel the regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China and India. In addition, government initiatives encouraging R&D activities are likely to boost industry expansion over this period. For instance, ‘Make in India’ initiative by Indian government encourages domestic manufacturing which will drive raw material demand from 2018 onwards; whereas ‘Made-in-China 2025’ policy aims at dominating various sectors including electronics & IT through innovation thus driving IVD production across Asia Pacific region (Korea & Japan).
Growth Factors:
- Increasing demand for point-of-care diagnostics: The increasing demand for rapid, accurate, and affordable diagnostic tests is driving the growth of the IVD raw materials market. This is because point-of-care diagnostics require less time and are easy to use, which makes them ideal for use in clinics and hospitals.
- Technological advancements: The development of new technologies such as next-generation sequencing (NGS) is aiding the growth of the IVD raw materials market by providing a more efficient way to detect genetic variations and mutations. Additionally, this technology can be used to identify biomarkers associated with various diseases, thus helping in their diagnosis and treatment.
- Rising prevalence of chronic diseases: The rising prevalence of chronic diseases such as cancer, diabetes mellitus, and cardiovascular disorders is leading to an increase in the demand for diagnostic tests worldwide. This is fueling the growth of the IVD raw materials market as these tests require specialized reagents and kits that are manufactured using high quality raw materials.
Scope Of The Report
Report Attributes
Report Details
Report Title
IVD Raw Materials Market Research Report
By Type
Antigen, Antibody, Diagnostic Enzymes, Others
By Application
Pharmaceutical Company, Laboratories, Hospitals, Others
By Companies
Roche, Life Technologies Corporation (Thermo Fisher), HyTest, Meridian Bioscience, Microbix biosystems, Fapon, Nanjing OkayBio, Technopath Clinical Diagnostics, Zoonbio Biotechnology Co., Ltd, Rockland Immunochemicals Inc., OYC Europe, SERION Immunologics, VirionSerion GmbH, PRAHAS Healthcare, Cusabio, Aalto Bio Reagents Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global IVD Raw Materials Market Report Segments:
The global IVD Raw Materials market is segmented on the basis of:
Types
Antigen, Antibody, Diagnostic Enzymes, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Company, Laboratories, Hospitals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Life Technologies Corporation (Thermo Fisher)
- HyTest
- Meridian Bioscience
- Microbix biosystems
- Fapon
- Nanjing OkayBio
- Technopath Clinical Diagnostics
- Zoonbio Biotechnology Co., Ltd
- Rockland Immunochemicals Inc.
- OYC Europe
- SERION Immunologics
- VirionSerion GmbH
- PRAHAS Healthcare
- Cusabio
- Aalto Bio Reagents Ltd
Highlights of The IVD Raw Materials Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antigen
- Antibody
- Diagnostic Enzymes
- Others
- By Application:
- Pharmaceutical Company
- Laboratories
- Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the IVD Raw Materials Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
IVD raw materials are the materials used in the production of IVDs. These materials can include plastics, metals, and other substances.
Some of the major players in the ivd raw materials market are Roche, Life Technologies Corporation (Thermo Fisher), HyTest, Meridian Bioscience, Microbix biosystems, Fapon, Nanjing OkayBio, Technopath Clinical Diagnostics, Zoonbio Biotechnology Co., Ltd, Rockland Immunochemicals Inc., OYC Europe, SERION Immunologics, VirionSerion GmbH, PRAHAS Healthcare, Cusabio, Aalto Bio Reagents Ltd.
The ivd raw materials market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 IVD Raw Materials Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 IVD Raw Materials Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 IVD Raw Materials Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the IVD Raw Materials Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global IVD Raw Materials Market Size & Forecast, 2018-2028
4.5.1 IVD Raw Materials Market Size and Y-o-Y Growth
4.5.2 IVD Raw Materials Market Absolute $ Opportunity
Chapter 5 Global IVD Raw Materials Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 IVD Raw Materials Market Size Forecast by Type
5.2.1 Antigen
5.2.2 Antibody
5.2.3 Diagnostic Enzymes
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global IVD Raw Materials Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 IVD Raw Materials Market Size Forecast by Applications
6.2.1 Pharmaceutical Company
6.2.2 Laboratories
6.2.3 Hospitals
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global IVD Raw Materials Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 IVD Raw Materials Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America IVD Raw Materials Analysis and Forecast
9.1 Introduction
9.2 North America IVD Raw Materials Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America IVD Raw Materials Market Size Forecast by Type
9.6.1 Antigen
9.6.2 Antibody
9.6.3 Diagnostic Enzymes
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America IVD Raw Materials Market Size Forecast by Applications
9.10.1 Pharmaceutical Company
9.10.2 Laboratories
9.10.3 Hospitals
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe IVD Raw Materials Analysis and Forecast
10.1 Introduction
10.2 Europe IVD Raw Materials Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe IVD Raw Materials Market Size Forecast by Type
10.6.1 Antigen
10.6.2 Antibody
10.6.3 Diagnostic Enzymes
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe IVD Raw Materials Market Size Forecast by Applications
10.10.1 Pharmaceutical Company
10.10.2 Laboratories
10.10.3 Hospitals
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific IVD Raw Materials Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific IVD Raw Materials Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific IVD Raw Materials Market Size Forecast by Type
11.6.1 Antigen
11.6.2 Antibody
11.6.3 Diagnostic Enzymes
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific IVD Raw Materials Market Size Forecast by Applications
11.10.1 Pharmaceutical Company
11.10.2 Laboratories
11.10.3 Hospitals
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America IVD Raw Materials Analysis and Forecast
12.1 Introduction
12.2 Latin America IVD Raw Materials Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America IVD Raw Materials Market Size Forecast by Type
12.6.1 Antigen
12.6.2 Antibody
12.6.3 Diagnostic Enzymes
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America IVD Raw Materials Market Size Forecast by Applications
12.10.1 Pharmaceutical Company
12.10.2 Laboratories
12.10.3 Hospitals
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) IVD Raw Materials Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) IVD Raw Materials Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) IVD Raw Materials Market Size Forecast by Type
13.6.1 Antigen
13.6.2 Antibody
13.6.3 Diagnostic Enzymes
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) IVD Raw Materials Market Size Forecast by Applications
13.10.1 Pharmaceutical Company
13.10.2 Laboratories
13.10.3 Hospitals
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 IVD Raw Materials Market: Competitive Dashboard
14.2 Global IVD Raw Materials Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Life Technologies Corporation (Thermo Fisher)
14.3.3 HyTest
14.3.4 Meridian Bioscience
14.3.5 Microbix biosystems
14.3.6 Fapon
14.3.7 Nanjing OkayBio
14.3.8 Technopath Clinical Diagnostics
14.3.9 Zoonbio Biotechnology Co., Ltd
14.3.10 Rockland Immunochemicals Inc.
14.3.11 OYC Europe
14.3.12 SERION Immunologics
14.3.13 VirionSerion GmbH
14.3.14 PRAHAS Healthcare
14.3.15 Cusabio
14.3.16 Aalto Bio Reagents Ltd
